In addition to diabetes, CISD1 expression impairment is also associated with tumor growth (such as breast cancer and liver cancer) and has been considered as a potential chemotherapy target (Salem et al., 2012; Sohn et al., 2013). This evidence concerns the gene CISD1 and breast carcinoma.